Sign in

CIK 0001824893

  • Non-accelerated filer
  • Smaller reporting company

Surrozen, Inc./DE

Sign in to watch
Ticker
SRZN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
301374889
Phone
+1 650-475-2820
Business address
171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Consonance-HFW Acquisition Corp.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4/A Open-market buy 10% owner bought 193,548 shares at $15.50 ($2,999,994)
  6. 4/A Open-market buy Director bought 193,548 shares at $15.50 ($2,999,994)
  7. 4 Open-market buy CFO and COO bought 1,474 shares
  8. 4 Open-market buy Chief Executive Officer bought 1,474 shares
  9. 4 Open-market buy Director bought 193,548 shares at $15.50 ($2,999,994)
  10. 4 Open-market buy 10% owner bought 193,548 shares at $15.50 ($2,999,994)
  11. 4 Derivatives Options or other derivatives
  12. 4 Grant or award Chief Financial Officer acquired 2,085 shares (grant or award)
  13. 4 Grant or award Exec. Vice President, Research acquired 2,085 shares (grant or award)
  14. 4 Grant or award Chief Executive Officer acquired 2,046 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award Chief Executive Officer acquired 25,000 shares (grant or award)
  17. 4 Grant or award Chief Scientific Officer acquired 17,638 shares (grant or award)
  18. 4 Grant or award Chief Financial Officer acquired 25,000 shares (grant or award)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 10 · 189 filings